HRMY Q1 2023 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$119M+39.6% YoY

Gross Profit

$98M82.6% margin

Operating Income

$40M33.9% margin

Net Income

$29M24.8% margin

EPS (Diluted)

$0.48

QoQ Revenue Growth

-7.2%

Cash Flow

Operating Cash Flow

$43M

Free Cash Flow

$43M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$715M

Total Liabilities

$272M

Stockholders' Equity

$443M

Cash & Equivalents

$288M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$119M	$85M	+39.6%
Gross Profit	$98M	$71M	+39.3%
Operating Income	$40M	$28M	+46.7%
Net Income	$29M	$21M	+37.2%

Geographic Segments

United States

$500M100%